Journal
TRENDS IN BIOTECHNOLOGY
Volume 25, Issue 1, Pages 24-32Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2006.10.010
Keywords
-
Categories
Ask authors/readers for more resources
Recent developments in the identification, in vitro culture and differentiation of stem cells point to the unprecedented potential of these cells, or their derivatives, to cure degenerative disorders. Human embryonic stem cells (hESC) offer the particular advantage of prolonged proliferative capacity and great versatility in the lineages that can be formed in culture. Translating these advantages into clinical benefits faces many challenges, including efficient differentiation into the desired cell type(s), maintaining genetic stability during long-term culture and, finally, ensuring the absence of potentially turnorigenic hESC from the final product. It is this final safety issue that will form the focus of this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available